Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.55M Buy
12,884
+310
+2% +$35.8K 0.13% 95
2025
Q4
$1.48M Buy
12,574
+9,879
+367% +$927K 0.12% 107
2025
Q3
$243K Hold
2,695
0.02% 168
2025
Q2
$226K Hold
2,695
0.02% 171
2025
Q1
$212K Hold
2,695
0.02% 163
2024
Q4
$269K Buy
+2,695
New +$278K 0.03% 148

Other funds holding MRK

Guardian Partners's MRK Position: Q1 2026 in Review

Guardian Partners increased its Merck (MRK) stake by 2.5% in Q1 2026, buying an estimated $35.8K and bringing the position to 12,884 shares worth $1.55M. The position accounts for 0.13% of the portfolio, ranked #95.

Guardian Partners first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Guardian Partners held 12,884 shares of Merck worth $1.55M as of Q1 2026.
  • Guardian Partners bought 310 Merck shares in Q1 2026, an estimated $35.8K.
  • Merck made up 0.13% of Guardian Partners's portfolio in Q1 2026, its #95 holding.
  • Guardian Partners first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Guardian Partners's 13F filing for Q1 2026, filed 18 May 2026.